US Patent Issued to The Trustees of Columbia University in the City of New York on June 23 for "Engineered osteocalcins for treating sarcopenia" (New York Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,521, issued on June 23, was assigned to The Trustees of Columbia University in the City of New York (New York).

"Engineered osteocalcins for treating sarcopenia" was invented by Gerard Karsenty (New York) and Julian Berger (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "Exemplary methods, compositions and uses thereof can be provided for preventing, reducing and/or treating loss of muscle function. In particular, e.g., it is possible to administer to a subject a pharmaceutical composition comprising a therapeutically effective amount of an agent that enhances Interleukin-6 (IL) release during exercise, and optionally a pharmaceutically acce...